249 related articles for article (PubMed ID: 26398719)
1. Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells (Review).
Li N; Huang D; Lu N; Luo L
Oncol Rep; 2015 Dec; 34(6):2821-6. PubMed ID: 26398719
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of Peutz-Jeghers mutations reveals that the LKB1 C-terminal region exerts a crucial role in regulating both the AMPK pathway and the cell polarity.
Forcet C; Etienne-Manneville S; Gaude H; Fournier L; Debilly S; Salmi M; Baas A; Olschwang S; Clevers H; Billaud M
Hum Mol Genet; 2005 May; 14(10):1283-92. PubMed ID: 15800014
[TBL] [Abstract][Full Text] [Related]
3. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
4. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism.
Jansen M; Ten Klooster JP; Offerhaus GJ; Clevers H
Physiol Rev; 2009 Jul; 89(3):777-98. PubMed ID: 19584313
[TBL] [Abstract][Full Text] [Related]
5. Posttranslational regulation of liver kinase B1 in human cancer.
Hu L; Liu M; Tang B; Li Q; Pan BS; Xu C; Lin HK
J Biol Chem; 2023 Apr; 299(4):104570. PubMed ID: 36870679
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppression by LKB1: SIK-ness prevents metastasis.
Shaw RJ
Sci Signal; 2009 Sep; 2(86):pe55. PubMed ID: 19724060
[TBL] [Abstract][Full Text] [Related]
7. The LKB1 tumor suppressor negatively regulates mTOR signaling.
Shaw RJ; Bardeesy N; Manning BD; Lopez L; Kosmatka M; DePinho RA; Cantley LC
Cancer Cell; 2004 Jul; 6(1):91-9. PubMed ID: 15261145
[TBL] [Abstract][Full Text] [Related]
8. Controlling the master-upstream regulation of the tumor suppressor LKB1.
Kullmann L; Krahn MP
Oncogene; 2018 Jun; 37(23):3045-3057. PubMed ID: 29540834
[TBL] [Abstract][Full Text] [Related]
9. LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases.
Zhang Y; Meng Q; Sun Q; Xu ZX; Zhou H; Wang Y
Mol Metab; 2021 Feb; 44():101131. PubMed ID: 33278637
[TBL] [Abstract][Full Text] [Related]
10. LKB1; linking cell structure and tumor suppression.
Hezel AF; Bardeesy N
Oncogene; 2008 Nov; 27(55):6908-19. PubMed ID: 19029933
[TBL] [Abstract][Full Text] [Related]
11. The molecular mechanisms that underlie the tumor suppressor function of LKB1.
Fan D; Ma C; Zhang H
Acta Biochim Biophys Sin (Shanghai); 2009 Feb; 41(2):97-107. PubMed ID: 19204826
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma.
Guldberg P; thor Straten P; Ahrenkiel V; Seremet T; Kirkin AF; Zeuthen J
Oncogene; 1999 Mar; 18(9):1777-80. PubMed ID: 10208439
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
Chen Y; Liu Y; Zhou Y; You H
Oncol Rep; 2019 Feb; 41(2):1035-1044. PubMed ID: 30483811
[TBL] [Abstract][Full Text] [Related]
14. Genetic screening for Peutz-Jeghers syndrome.
Ballhausen WG; Günther K
Expert Rev Mol Diagn; 2003 Jul; 3(4):471-9. PubMed ID: 12877386
[TBL] [Abstract][Full Text] [Related]
15. LKB1 tumor suppressor protein regulates actin filament assembly through Rho and its exchange factor Dbl independently of kinase activity.
Xu X; Omelchenko T; Hall A
BMC Cell Biol; 2010 Oct; 11():77. PubMed ID: 20939895
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients.
Boudeau J; Kieloch A; Alessi DR; Stella A; Guanti G; Resta N
Hum Mutat; 2003 Feb; 21(2):172. PubMed ID: 12552571
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of aromatase associated with loss of heterozygosity of the STK11 gene accounts for prepubertal gynecomastia in boys with Peutz-Jeghers syndrome.
Ham S; Meachem SJ; Choong CS; Charles AK; Baynam GS; Jones TW; Samarajeewa NU; Simpson ER; Brown KA
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1979-87. PubMed ID: 24037887
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.
Corradetti MN; Inoki K; Bardeesy N; DePinho RA; Guan KL
Genes Dev; 2004 Jul; 18(13):1533-8. PubMed ID: 15231735
[TBL] [Abstract][Full Text] [Related]
19. LKB1: a sweet side to Peutz-Jeghers syndrome?
Carling D
Trends Mol Med; 2006 Apr; 12(4):144-7. PubMed ID: 16530014
[TBL] [Abstract][Full Text] [Related]
20. Mir-451 inhibits proliferation and migration of non-small cell lung cancer cells via targeting LKB1/AMPK.
Liu Y; Li H; Li LH; Tang JB; Sheng YL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):274-280. PubMed ID: 31389598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
